Last €0.70 EUR
Change Today +0.0005 / 0.07%
Volume 38.2K
PRL On Other Exchanges
Symbol
Exchange
BrsaItaliana
As of 11:30 AM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

pierrel spa (PRL) Snapshot

Open
€0.71
Previous Close
€0.70
Day High
€0.71
Day Low
€0.70
52 Week High
04/8/14 - €0.85
52 Week Low
12/20/13 - €0.49
Market Cap
34.6M
Average Volume 10 Days
106.4K
EPS TTM
€-0.44
Shares Outstanding
49.4M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for PIERREL SPA (PRL)

Related News

No related news articles were found.

pierrel spa (PRL) Related Businessweek News

No Related Businessweek News Found

pierrel spa (PRL) Details

Pierrel S.p.A. provides contract research and manufacturing services to the pharmaceutical and life science industries. The company is involved in the development of various types of drugs, such as tube vials, bottles, ampoules, drops, sprays, syrups, gels, creams, ointments, and tablets; and production of active ingredients, including active substances and pharmaceutical formulations. It also provides consulting and operational services for the research and development of new molecules and drug products; and consulting services for clinical and regulatory development programs, as well as operational services for the execution of international phase I-IV, late phase, and non-interventional clinical trials. Pierrel S.p.A. has an agreement with Tixupharma for the development and sale of a device to treat periodontitis patients. The company operates in the United States, Australia, Canada, Russia, and the Middle East. Pierrel S.p.A. is based in Capua, Italy.

pierrel spa (PRL) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

pierrel spa (PRL) Key Developments

Pierrel SpA Announces Consolidated Earnings Results for the First Half of 2014; Revised Earnings Guidance for the Years 2014, 2015 and 2016

Pierrel SpA announced consolidated earnings results for the first half of 2014. Consolidated net loss came in at EUR 12.6 million (USD 16.5 million) in the first half of 2014, compared with a EUR 5.7 million net loss for the same period last year. Revenues fell 2.9% to EUR 15.3 million. Operating loss increased to EUR 11.1 million from EUR 4.8 million. For 2014, Pierrel sees a consolidated gross operating loss at EUR 5.4 million, compared with an expected gross operating profit of EUR 3.5 million. The 2015 earnings before interest, tax, depreciation and amortisation (EBITDA) is seen at the break-even point, compared with a previous forecast for EUR 6.2 million in EBITDA. The company cut its guidance for 2014-2016, expecting revenues of some EUR 35.1 million in 2014, down from previously forecast EUR 45.3 million. The 2015 revenue projection was lowered to EUR 39.2 million from EUR 51 million, and the 2016 revenue guidance was cut to EUR 48.7 million from EUR 55.5 million. The company expects its 2016 EBITDA at some EUR 5.7 million compared with a previous projection of EUR 7.3 million.

Pierrel S.p.A. to Report Q2, 2014 Results on Aug 29, 2014

Pierrel S.p.A. announced that they will report Q2, 2014 results on Aug 29, 2014

Pierrel S.p.A., Board Meeting, Aug 29, 2014

Pierrel S.p.A., Board Meeting, Aug 29, 2014. Agenda: To consider and approve the interim condensed consolidated financial statements of the group period ended June 30, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PRL:IM €0.70 EUR +0.0005

PRL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PRL.
View Industry Companies
 

Industry Analysis

PRL

Industry Average

Valuation PRL Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PIERREL SPA, please visit www.pierrel.it. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.